Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)

David J. Sas, Peter C. Harris, Dawn S. Milliner

Research output: Contribution to journal › Comment/debate

Abstract

The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”.

Original languageEnglish (US)
JournalUrolithiasis
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Potassium Citrate
Hyperoxaluria
Urolithiasis

ASJC Scopus subject areas

  • Urology

Cite this

Correction to : Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3). / Sas, David J.; Harris, Peter C.; Milliner, Dawn S.

In: Urolithiasis, 01.01.2019.

Research output: Contribution to journal › Comment/debate

Sas, DJ, Harris, PC & Milliner, DS 2019, 'Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)', Urolithiasis. https://doi.org/10.1007/s00240-019-01166-6
Sas DJ, Harris PC, Milliner DS. Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3). Urolithiasis. 2019 Jan 1. https://doi.org/10.1007/s00240-019-01166-6
Sas, David J. ; Harris, Peter C. ; Milliner, Dawn S. / Correction to : Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3). In: Urolithiasis. 2019.
@article{e2492e5d764a48a2b69d713130074e30,
title = "Correction to: Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)",
abstract = "The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”.",
author = "Sas, {David J.} and Harris, {Peter C.} and Milliner, {Dawn S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00240-019-01166-6",
language = "English (US)",
journal = "Urolithiasis",
issn = "2194-7228",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Correction to

T2 - Recent advances in the identification and management of inherited hyperoxalurias (Urolithiasis, (2019), 47, 1, (79-89), 10.1007/s00240-018-1093-3)

AU - Sas, David J.

AU - Harris, Peter C.

AU - Milliner, Dawn S.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”.

AB - The original version of this article unfortunately contained a mistake. On page 84, the dose for oral potassium citrate is incorrectly written as “0.1 mg/kg/day divided BID-QID for children, 30–60 mg per day divided BID-QID for adults”.

UR - http://www.scopus.com/inward/record.url?scp=85074053468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074053468&partnerID=8YFLogxK

U2 - 10.1007/s00240-019-01166-6

DO - 10.1007/s00240-019-01166-6

M3 - Comment/debate

C2 - 31606780

AN - SCOPUS:85074053468

JO - Urolithiasis

JF - Urolithiasis

SN - 2194-7228

ER -

Access to Document